Allopurinol/Tranilast

别嘌呤/曲尼司特

Report date: 2022/07/19 20:00:45

Base Information

Drug NameAllopurinol/Tranilast
Drug Alias NameTranilast and Allopurinol曲尼司特/别嘌呤别嘌呤曲尼司特Allopurinol and Tranilast曲尼司特别嘌呤 +[7] 
ClassificationSmall molecules
Mechanisms of ActionXanthine dehydrogenase inhibitors
TargetsXanthine dehydrogenase
Therapy Area/IndicationsHyperuricemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes AllopurinolTranilast
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNuon Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNuon Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsHyperuricemia

Other Information

ATC CodeN/A
Related LinksN/A